NL
DE
7 April 2020
Funding for this consortium was granted by the Institute for Chemical Immunology (ICI). Five PhD candidates will work in close collaboration to synthesize multimodal vaccine conjugates to specifically deliver tumor epitopes and immunomodulating adjuvants to dendritic cells with the aim to elicit specific T cell responses. Using state-of-the-art chemical strategies and super-resolution imaging techniques, conjugates bearing bioorthogonal trackable epitopes will be characterized at cell biological level.
This will provide valuable structure-activity relationship data when correlated to in vitro and in vivo immunological outcome, which will allow the consortium to rationally design further optimized vaccine conjugates.
Funding for this consortium was granted by the Institute for Chemical Immunology (ICI). Five PhD candidates will work in close collaboration to synthesize multimodal vaccine conjugates to specifically deliver tumor epitopes and immunomodulating adjuvants to dendritic cells with the aim to elicit specific T cell responses. Using state-of-the-art chemical strategies and super-resolution imaging techniques, conjugates bearing bioorthogonal trackable epitopes will be characterized at cell biological level.
This will provide valuable structure-activity relationship data when correlated to in vitro and in vivo immunological outcome, which will allow the consortium to rationally design further optimized vaccine conjugates.
Related news items
Camille Le Gall reports an efficient approach for delivery of poorly soluble tumor antigens to human cDC1s
20 April 2022 Camille Le Gall published about an efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion in the Journal of Immunotherapy of Cancer. read more
Three VIDI grants for RIMLS researchers
24 May 2019 Matthijs Jore, Daniele Tauriello and Johannes Textor are each to receive up to 800,000 euros to develop an innovative research theme and to build up their own research group. NWO is awarding the Vidi grant as part of the Innovational Research Incentives Scheme. read more
Publication on nanoparticle imaging agent
22 March 2019 Mangala Srinivas, theme Nanomedicine, showed in Advanced Functional Materials that nano‐particles (radius 100 nm), are suitable for long‐term in vivo ultrasound in combination with 19F MRI and fluorescence. read more
RIMLS awards festival Twelve winners
16 January 2019 In 5 categories RIMLS young researchers received an award and bonus during the New Year's drinks. See all photo's. read more
Rare immune cells kickstart anti-cancer immune response
3 September 2018 Florian Wimmers, theme Cancer development and immune defense, and colleagues developed a high-throughput nano lab to shed light on this process. Their findings were published in Nature Communications. read more
